Premium
Obtention Production and Use of Factor VIII in Costa Rica
Author(s) -
Cordero R,
Montero C
Publication year - 1984
Publication title -
scandinavian journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0036-553X
DOI - 10.1111/j.1600-0609.1984.tb02610.x
Subject(s) - blood bank , production (economics) , business , agricultural science , medicine , environmental science , emergency medicine , economics , macroeconomics
The National Blood Commission integrated by members of the Costa Rican Red Cross, the Voluntary Blood Donors and the National Health System has an excellent program to obtain blood, plasma, platelets and cryoprecipitates. The blood is obtained on voluntary basis from several sources such as universities, high schools, industries and public workers. The daily fresh plasma obtained in this form is processed by Dr. Pool's method to produce cryoprecipitates, which are used at the National Hemophilia Center. The obtention of cryoprecipitates produces an annual average of 500,000 U F VIII. In order to fulfill the requirements for home care and rural hospitals, it is necessary to import commercial concentrates of F VIII. There is a possibility to either lyophilize cryoprecipitates or exchange the remanent plasma for concentrates. It is suggested that a regional plasma fractionating plant is installed in order to fill the needs of Central America and the Caribbean area.